Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Segura

Showing results (241-250 of 250) with videos related to

Pageof 25
Sort By:
You have reached the last page of results.This site can display upto 250 results.
Molecular Cell|June 9, 2015
Histone Variant H2A.Z.2 Mediates Proliferation and Drug Sensitivity of Malignant MelanomaChiara Vardabasso, Alexandre Gaspar-Maia, Dan Hasson, et al.
Oncogene|March 22, 2016
BRG1/SMARCA4 is essential for neuroblastoma cell viability through modulation of cell death and survival pathwaysL Jubierre, A Soriano, L Planells-Ferrer, et al.
Oncogene|July 7, 2019
MicroRNA-654-5p suppresses ovarian cancer development impacting on MYC, WNT and AKT pathwaysBlanca Majem, Alfonso Parrilla, Carlos Jiménez, et al.
Small (Weinheim an Der Bergstrasse, Germany)|November 17, 2021
Engineering pH-Sensitive Stable Nanovesicles for Delivery of MicroRNA TherapeuticsAriadna Boloix, Natalia Feiner-Gracia, Mariana Köber, et al.
Autophagy|May 14, 2020
The anti-cancer drug ABTL0812 induces ER stress-mediated cytotoxic autophagy by increasing dihydroceramide levels in cancer cellsPau Muñoz-Guardiola, Josefina Casas, Elisabet Megías-Roda, et al.
Oncotarget|November 16, 2017
MicroRNA-200, associated with metastatic breast cancer, promotes traits of mammary luminal progenitor cellsLourdes Sánchez-Cid, Mònica Pons, Juan José Lozano, et al.
Cellular and Molecular Life Sciences : CMLS|October 11, 2022
Integrin alpha9 emerges as a key therapeutic target to reduce metastasis in rhabdomyosarcoma and neuroblastomaNatalia Navarro, Carla Molist, Júlia Sansa-Girona, et al.
Clinical and Translational Medicine|October 28, 2021
The oral KIF11 inhibitor 4SC-205 exhibits antitumor activity and potentiates standard and targeted therapies in primary and metastatic neuroblastoma modelsMarc Masanas, Nuria Masiá, Leticia Suárez-Cabrera, et al.
Cancer Cell|October 22, 2019
ATRX In-Frame Fusion Neuroblastoma Is Sensitive to EZH2 Inhibition via Modulation of Neuronal Gene SignaturesZulekha A Qadeer, David Valle-Garcia, Dan Hasson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 2, 2015
Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in EuropeL Marije Hofstra, Nicolas Sauvageot, Jan Albert, et al.
Pageof 25

Showing results (241-250 of 250) with videos related to

Sort By:
Pageof 25
You have reached the last page of results.This site can display upto 250 results.
Molecular Cell|June 9, 2015
Histone Variant H2A.Z.2 Mediates Proliferation and Drug Sensitivity of Malignant MelanomaChiara Vardabasso, Alexandre Gaspar-Maia, Dan Hasson, et al.
Oncogene|March 22, 2016
BRG1/SMARCA4 is essential for neuroblastoma cell viability through modulation of cell death and survival pathwaysL Jubierre, A Soriano, L Planells-Ferrer, et al.
Oncogene|July 7, 2019
MicroRNA-654-5p suppresses ovarian cancer development impacting on MYC, WNT and AKT pathwaysBlanca Majem, Alfonso Parrilla, Carlos Jiménez, et al.
Small (Weinheim an Der Bergstrasse, Germany)|November 17, 2021
Engineering pH-Sensitive Stable Nanovesicles for Delivery of MicroRNA TherapeuticsAriadna Boloix, Natalia Feiner-Gracia, Mariana Köber, et al.
Autophagy|May 14, 2020
The anti-cancer drug ABTL0812 induces ER stress-mediated cytotoxic autophagy by increasing dihydroceramide levels in cancer cellsPau Muñoz-Guardiola, Josefina Casas, Elisabet Megías-Roda, et al.
Oncotarget|November 16, 2017
MicroRNA-200, associated with metastatic breast cancer, promotes traits of mammary luminal progenitor cellsLourdes Sánchez-Cid, Mònica Pons, Juan José Lozano, et al.
Cellular and Molecular Life Sciences : CMLS|October 11, 2022
Integrin alpha9 emerges as a key therapeutic target to reduce metastasis in rhabdomyosarcoma and neuroblastomaNatalia Navarro, Carla Molist, Júlia Sansa-Girona, et al.
Clinical and Translational Medicine|October 28, 2021
The oral KIF11 inhibitor 4SC-205 exhibits antitumor activity and potentiates standard and targeted therapies in primary and metastatic neuroblastoma modelsMarc Masanas, Nuria Masiá, Leticia Suárez-Cabrera, et al.
Cancer Cell|October 22, 2019
ATRX In-Frame Fusion Neuroblastoma Is Sensitive to EZH2 Inhibition via Modulation of Neuronal Gene SignaturesZulekha A Qadeer, David Valle-Garcia, Dan Hasson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 2, 2015
Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in EuropeL Marije Hofstra, Nicolas Sauvageot, Jan Albert, et al.
Pageof 25